Todd Brady is the founder of Aldeyra Therapeutics. Aldeyra Therapeutics has raised $500M in total funding. Based in Lexington, Massachusetts.
Todd Brady is the CEO of Aldeyra Therapeutics, a biotech company focused on developing drugs for immune and inflammatory diseases. He has led the company to raise over half a billion dollars, with a market cap of approximately $250 million and two drugs in Phase 3 trials.
Full founder directory · Investor directory · Company funding database · Fundraising library